Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin Nanogels vs Fluocinolone Acetonide in Oral Lichen Planus
NCT06932848Recruiting
- Sponsor
- Chulalongkorn University
- Start
- Jun 2025
- Primary completion
- Jun 2026
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of curcumin in oral lichen planus (OLP) (2 arms), sponsored by Chulalongkorn University. Primary endpoint: Oral Lichen Planus Disease Activity Scale at 4 weeks. Started Jun 2025; status: recruiting.
02
Drugs
curcumin
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on NCT06932848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06932848.